Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. [electronic resource]
Producer: 20060522Description: 521-7 p. digitalISSN:- 0003-9942
- Adolescent
- Adult
- Anemia -- chemically induced
- Chelating Agents -- administration & dosage
- Copper -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Hepatolenticular Degeneration -- drug therapy
- Humans
- Length of Stay
- Male
- Middle Aged
- Molybdenum -- administration & dosage
- Serum Albumin -- drug effects
- Speech -- drug effects
- Speech Disorders -- drug therapy
- Treatment Outcome
- Trientine -- administration & dosage
- Zinc -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.